EGFR and neoplasm: In both cases, the clinical course and previous genetic findings suggest that both EGFR T790M mutations emerged in metastatic lesions that were not captured by tumor biopsies, illustrating the potential of ctDNA for the characterization of tumor heterogeneity [39].